Epinex's Patent Granted for Revolutionary Diabetes Test (Marketwire)

2 March 2010, 4:47 am

TUSTIN, CA--(Marketwire - March 2, 2010) - The United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1AT Rapid Diabetes Monitoring Index Test . The patent (US7659107B2) is for the first ever rapid glycated albumin test and instrument, which could redefine the way diabetes is monitored for over 250 million diabetics worldwide.... Read More »

More Topics from "News"

• A Luxury Standard Rockets I-5 Self Storage to Number One in the Nation (PRWeb via Yahoo! News)
• 'Spa' 1510 AM goes talk; includes Mancow, Savage (Orange County Register)
• A New Network Time Server and Master Clock in One! (PRWeb via Yahoo! News)
• Sheriff's Patrol Log: Multiple suspects assault victims at Castroville business (The Salinas Californian)
• AE Linux Is Available on Cinnamon Bay SBC Featuring Intel(R) Atom(TM) Processors (Marketwire)
• AE Linux Is Available on Cinnamon Bay SBC Featuring Intel(R) Atom(TM) Processors (Marketwire via Yahoo! Finance)
• Epinex's Patent Granted for Revolutionary Diabetes Test (Marketwire via Yahoo! Finance)
• Things to do in Tustin: Business tips; Sheriff Candidates Forum (Tustin News)
• OUTDOORS: Weekly fishing report, Feb. 25 (North County Times)